NCT07165210Recruiting
Incidence of 106TBL Lymph Node Metastasis
A Prospective Observational Study of Left Tracheobronchial Lymph Node Metastasis in Patients With Esophageal Cancer
Source: ClinicalTrials.gov · Last updated 10 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
the study was to document the incidence of left tracheobronchial lymph node metastasis, and the risk factors of metastasis.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1852 (estimated)
- First submitted
- 3 Sept 2025
- Start date
- 21 Jul 2025
- Primary completion date
- 21 Jul 2027
- Lead sponsor
- Fudan University
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT07165210
What you commit to
- Study type: Observational
- Planned participants: 1852
- From 21 Jul 2025 to the primary completion date, 21 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- esophageal cancer in the neck
Other
- poor physical status to have esophagectomy.
Who the study is looking for
- patients with esophageal squamous cell carcinoma
- clinical staging: cT1-4a N0/+ M0.
- no history of other malignancy.
Age in the registry: 20 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fudan University Shanghai Cancer Center Coordinator of this site? Confirm its status | Shanghai | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.